KNOTT DAVID M - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
KNOTT DAVID M ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,650,000
-15.6%
49,592
-1.6%
0.60%
-13.7%
Q2 2021$1,954,000
-22.0%
50,373
-3.1%
0.70%
-35.2%
Q1 2021$2,505,000
-5.1%
51,973
+2.4%
1.07%
-10.3%
Q4 2020$2,641,000
+94.3%
50,7730.0%1.20%
+49.9%
Q3 2020$1,359,000
+480.8%
50,773
+323.1%
0.80%
+522.7%
Q2 2020$234,00012,0000.13%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders